Two Cases of Hand-Foot Syndrome Induced by Sunitinib / 대한피부과학회지
Korean Journal of Dermatology
;
: 1236-1239, 2008.
Artigo
em Coreano
| WPRIM
| ID: wpr-40579
ABSTRACT
Sunitinib (SU11248) is a novel orally administered small molecule that inhibits multiple receptor tyrosine kinases so that can block tumor growth and angiogenesis. It was approved on 2006, for the treatment of advanced renal cell carcinoma and gastrointestinal stromal tumor. Various cutaneous adverse reactions induced by sunitinib have been reported, including hand-foot syndrome. We report two cases of hand-foot syndrome induced by sunitinib for treatment of advanced renal cell carcinoma.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Fosfotransferases
/
Pirróis
/
Tirosina
/
Carcinoma de Células Renais
/
Tumores do Estroma Gastrointestinal
/
Síndrome Mão-Pé
/
Indóis
Idioma:
Coreano
Revista:
Korean Journal of Dermatology
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS